🇺🇸 FDA
Patent

US 9382536

Antisense antiviral compounds and methods for treating a filovirus infection

granted A61KA61K31/675A61K31/713

Quick answer

US patent 9382536 (Antisense antiviral compounds and methods for treating a filovirus infection) held by Sarepta Therapeutics, Inc. expires Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sarepta Therapeutics, Inc.
Grant date
Tue Jul 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/675, A61K31/713, A61P, A61P31/00